314 related articles for article (PubMed ID: 17619155)
1. Lack of evidence for effect modification by estrogen of association between body mass index and colorectal cancer risk among postmenopausal women.
Wang Y; Jacobs EJ; Teras LR; Pavluck AL; Rodriguez C; Thun MJ; Calle EE
Cancer Causes Control; 2007 Oct; 18(8):793-9. PubMed ID: 17619155
[TBL] [Abstract][Full Text] [Related]
2. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype.
McCullough ML; Patel AV; Patel R; Rodriguez C; Feigelson HS; Bandera EV; Gansler T; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):73-9. PubMed ID: 18187388
[TBL] [Abstract][Full Text] [Related]
3. Body mass index and risk of colorectal cancer in women (United States).
Lin J; Zhang SM; Cook NR; Rexrode KM; Lee IM; Buring JE
Cancer Causes Control; 2004 Aug; 15(6):581-9. PubMed ID: 15280637
[TBL] [Abstract][Full Text] [Related]
4. Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women.
Rodriguez C; Calle EE; Fakhrabadi-Shokoohi D; Jacobs EJ; Thun MJ
Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):822-8. PubMed ID: 12223425
[TBL] [Abstract][Full Text] [Related]
5. Do factors related to endogenous and exogenous estrogens modify the relationship between obesity and risk of colorectal adenomas in women?
Wolf LA; Terry PD; Potter JD; Bostick RM
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):676-83. PubMed ID: 17416757
[TBL] [Abstract][Full Text] [Related]
6. Body mass index, body height, and subsequent risk of colorectal cancer in middle-aged and elderly Japanese men and women: Japan public health center-based prospective study.
Otani T; Iwasaki M; Inoue M;
Cancer Causes Control; 2005 Sep; 16(7):839-50. PubMed ID: 16132794
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer incidence and postmenopausal hormone use by type, recency, and duration in cancer prevention study II.
Hildebrand JS; Jacobs EJ; Campbell PT; McCullough ML; Teras LR; Thun MJ; Gapstur SM
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2835-41. PubMed ID: 19843681
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy and the risk of incident congestive heart failure: the Cardiovascular Health Study.
Rea TD; Psaty BM; Heckbert SR; Cushman M; Meilahn E; Olson JL; Lemaitre RN; Smith NL; Sotoodehnia N; Chaves PH
J Womens Health (Larchmt); 2003 May; 12(4):341-50. PubMed ID: 12804341
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (United States).
Purdue MP; Mink PJ; Hartge P; Huang WY; Buys S; Hayes RB
Cancer Causes Control; 2005 Oct; 16(8):965-73. PubMed ID: 16132805
[TBL] [Abstract][Full Text] [Related]
10. Body mass and colorectal cancer risk in the NIH-AARP cohort.
Adams KF; Leitzmann MF; Albanes D; Kipnis V; Mouw T; Hollenbeck A; Schatzkin A
Am J Epidemiol; 2007 Jul; 166(1):36-45. PubMed ID: 17449892
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of waist circumference and body mass index in relation to colorectal cancer incidence.
Wang Y; Jacobs EJ; Patel AV; Rodríguez C; McCullough ML; Thun MJ; Calle EE
Cancer Causes Control; 2008 Sep; 19(7):783-92. PubMed ID: 18322811
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
Windler E; Zyriax BC; Eidenmüller B; Boeing H
Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
[TBL] [Abstract][Full Text] [Related]
13. Body composition and breast cancer in postmenopausal women: a Danish prospective cohort study.
Mellemkjaer L; Bigaard J; Tjønneland A; Christensen J; Thomsen B; Johansen C; Overvad K; Olsen JH
Obesity (Silver Spring); 2006 Oct; 14(10):1854-62. PubMed ID: 17062817
[TBL] [Abstract][Full Text] [Related]
14. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
[TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy in relation to risk of cataract extraction: a prospective study of women.
Lindblad BE; Håkansson N; Philipson B; Wolk A
Ophthalmology; 2010 Mar; 117(3):424-30. PubMed ID: 20045566
[TBL] [Abstract][Full Text] [Related]
16. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women.
Tamimi RM; Hankinson SE; Chen WY; Rosner B; Colditz GA
Arch Intern Med; 2006 Jul; 166(14):1483-9. PubMed ID: 16864758
[TBL] [Abstract][Full Text] [Related]
17. Reproductive factors, exogenous female hormone use and colorectal cancer risk: the Japan Public Health Center-based Prospective Study.
Akhter M; Inoue M; Kurahashi N; Iwasaki M; Sasazuki S; Tsugane S;
Eur J Cancer Prev; 2008 Nov; 17(6):515-24. PubMed ID: 18941373
[TBL] [Abstract][Full Text] [Related]
18. Height and body mass index in relation to colorectal and gallbladder cancer in two million Norwegian men and women.
Engeland A; Tretli S; Austad G; Bjørge T
Cancer Causes Control; 2005 Oct; 16(8):987-96. PubMed ID: 16132807
[TBL] [Abstract][Full Text] [Related]
19. Body mass index and mortality among older breast cancer survivors in the Study of Osteoporotic Fractures.
Reeves KW; Faulkner K; Modugno F; Hillier TA; Bauer DC; Ensrud KE; Cauley JA;
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1468-73. PubMed ID: 17627012
[TBL] [Abstract][Full Text] [Related]
20. Body mass index increases risk of colorectal adenomas in men with Lynch syndrome: the GEOLynch cohort study.
Botma A; Nagengast FM; Braem MG; Hendriks JC; Kleibeuker JH; Vasen HF; Kampman E
J Clin Oncol; 2010 Oct; 28(28):4346-53. PubMed ID: 20733131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
